Recombinant CD79B (Polatuzumab Biosimilar) antibody

Catalog No. ABIN7488017

The Mammalian Cells Monoclonal anti-CD79B (Polatuzumab Biosimilar) antibody has been validated for . It is suitable to detect CD79B (Polatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD79B (Polatuzumab Biosimilar) antibody (ABIN7488017)

Target: CD79B (Polatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD79B (Polatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Polatuzumab Biosimilar - Anti-CD79B(CD79b, B29, IGB, Ig-beta) mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD79B (Polatuzumab Biosimilar)

Target: CD79B (Polatuzumab Biosimilar)

Target Type: Biosimilar